The bad news is that El Sid had similar success you don?t say in his fifth and sixth seasons before completely

The bad news is that El Sid had similar success (you don?t say) in his fifth and sixth seasons, before completely dropping off the table ever since.As I chose to do with Ponson, I focus on and root for the former with Cabrera. It?s a hope against hope, because there needs to be a whole lotta magic in Birdland for a 6?9? enigma to solve the riddle before becoming a career-long mystery Too bad his doppelganger never could.. * Ibuprofen, naproxen do not protect against disease Bonds * Findings contradict studies in younger people By Julie Steenhuysen CHICAGO, April 22 (Reuters) - Contrary to earlier findings,taking common painkillers such as ibuprofen and naproxen maynot prevent Alzheimer's disease, but may delay it, U.S.researchers said on Wednesday. Earlier studies had suggested that drugs known asnon-steroidal anti-inflammatories or NSAIDS, which also includeaspirin, could protect people from dementia. But a large study with older patients done by researchersat the University of Washington and the U.S.

Department ofVeterans Affairs in Seattle found the dementia risk wasactually higher among heavy NSAID users. The findings contradict the results of several studies thatfound drugs like ibuprofen -- sold under many brand names,including Motrin and Advil -- and naproxen, sold as Aleve, canprevent Alzheimer's disease. Researchers are struggling to find ways to protect againstAlzheimer's, a mind-robbing disease with no cure and feweffective treatments. Alzheimer's disease has been linked with inflammation, andresearchers have assumed that anti-inflammatory drugs mighthelp delay onset of the disease Dr.

John Breitner and colleagues studied 2,736 members of alarge health system who had an average age of 75 and no signsof dementia when they started. Of the participants, 351 people had a history of heavy useof NSAIDs at the start of the study, and another 107 peoplebecame heavy NSAID users during the 12-year follow-up period. During the study, 476 people developed Alzheimer's diseaseor dementia. The risk of developing dementia among heavy NSAIDusers was 66 percent higher than among people with little or noNSAID use. Breitner and colleagues think age may help explaindifferences between their findings and other studies showing aprevention benefit.